Baker Avenue Asset Management’s Steris STE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$388K Buy
1,845
+895
+94% +$192K 0.01% 591
2026
Q1
$210K Sell
950
-7
-0.7% -$1.71K ﹤0.01% 715
2025
Q4
$243K Buy
957
+66
+7% +$16.6K 0.01% 564
2025
Q3
$221K Buy
+891
New +$213K 0.01% 565
2023
Q4
Sell
-301
Closed -$66K 1338
2023
Q3
$66K Hold
301
﹤0.01% 487
2023
Q2
$67.7K Buy
301
+1
+0.3% +$200 ﹤0.01% 484
2023
Q1
$57.4K Hold
300
﹤0.01% 513
2022
Q4
$55.4K Buy
+300
New +$52.7K ﹤0.01% 481

Other funds holding STE

Baker Avenue Asset Management's STE Position: Q2 2026 in Review

Baker Avenue Asset Management increased its Steris (STE) stake by 94% in Q2 2026, buying an estimated $192K and bringing the position to 1,845 shares worth $388K. The position accounts for 0.01% of the portfolio, ranked #591.

Baker Avenue Asset Management first reported a position in STE in Q4 2022 and has held it in 8 quarters since. 835 funds tracked by Wall St. Rank hold STE as of Q2 2026.

  • Baker Avenue Asset Management held 1,845 shares of Steris worth $388K as of Q2 2026.
  • Baker Avenue Asset Management bought 895 Steris shares in Q2 2026, an estimated $192K.
  • Steris made up 0.01% of Baker Avenue Asset Management's portfolio in Q2 2026, its #591 holding.
  • Baker Avenue Asset Management first reported a position in Steris in Q4 2022 and has held it in 8 quarters since.
  • 835 funds tracked by Wall St. Rank held Steris as of Q2 2026.

Based on Baker Avenue Asset Management's 13F filing for Q2 2026, filed 28 Jul 2026.